Decreasing Incidence of Inflammatory Bowel Disease in Eastern Canada: a Population Database Study

Overview

Journal BMC Gastroenterol

Publisher Biomed Central

Specialty Gastroenterology

Date 2014 Aug 11

PMID 25108544

Citations 26

Authors

Desmond Leddin

Hala Tamim

Adrian R Levy

Affiliations

Soon will be listed here.

Abstract

Background: Nova Scotia has one of the highest incidences of inflammatory bowel disease (IBD) in the world. We wished to determine trends of IBD over time.

Methods: All Provincial residents have government provided health insurance and all interactions with the hospital, and physician billing systems, are captured on an administrative database. We used a validated measure to define incident cases of Crohn's (CD), ulcerative colitis (UC) and undifferentiated IBD (IBDU). Incidence rates of these diseases for the years 1996-2009 were calculated.

Results: Over the study period, 7,153 new cases of IBD were observed of which 3,046 cases were categorized as CD (42.6%), 2,960 as UC (41.4%) and 1,147 as IBDU (16.0%). Annual age standardized incidence rates were very high but have declined for CD from 27.4 to 17.7/100,000 population and for UC from 21.4 to 16.7/100,000. The decline was seen in all age groups and both genders. The decrease was not explained by a small increase in IBDU.

Conclusion: The incidence of CD and UC are decreasing in Nova Scotia. If replicated elsewhere this indicates a reversal after a long period of increasing occurrence of IBD. This has implications for both epidemiology and health planning.

Citing Articles

Influence of biological sex in inflammatory bowel diseases.

Tshikudi D, Bernstein C, Mishra S, Ghia J, Armstrong H Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39962330 DOI: 10.1038/s41575-025-01038-y.

Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease updated in 2023.

Yen H, Wu J, Wang H, Chang T, Chang C, Chang C Intest Res. 2024; 22(3):213-249.

PMID: 39099217 PMC: 11309818. DOI: 10.5217/ir.2023.00050.

Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?.

Park S Intest Res. 2022; 20(2):159-164.

PMID: 35508952 PMC: 9081986. DOI: 10.5217/ir.2021.00115.

Rising Healthcare Costs and Utilization among Young Adults with Cirrhosis in Ontario: A Population-Based Study.

Ames J, Djerboua M, Terrault N, Booth C, Flemming J Can J Gastroenterol Hepatol. 2022; 2022:6175913.

PMID: 35308801 PMC: 8926479. DOI: 10.1155/2022/6175913.

Population-Based Evidence From a Western Canadian Province of the Decreasing Incidence Rates and Trends of Inflammatory Bowel Disease Among Adults.

Osei J, Pena-Sanchez J, Fowler S, Muhajarine N, Kaplan G, Lix L J Can Assoc Gastroenterol. 2021; 4(4):186-193.

PMID: 34337319 PMC: 8320288. DOI: 10.1093/jcag/gwaa028.

References

Prenzel F, Uhlig H . Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis. J Crohns Colitis. 2010; 3(4):277-81. DOI: 10.1016/j.crohns.2009.07.001. View

De Wals P, Tairou F, Van Allen M, Uh S, Lowry R, Sibbald B . Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med. 2007; 357(2):135-42. DOI: 10.1056/NEJMoa067103. View

Geboes K, Colombel J, Greenstein A, Jewell D, Sandborn W, Vatn M . Indeterminate colitis: a review of the concept--what's in a name?. Inflamm Bowel Dis. 2008; 14(6):850-7. DOI: 10.1002/ibd.20361. View

SEDLACK R, Nobrega F, Kurland L, SAUER W . Inflammatory colon disease in Rochester, Minnesota, 1935-1964. Gastroenterology. 1972; 62(5):935-41. View

Bernstein C, Wajda A, Svenson L, MacKenzie A, Koehoorn M, Jackson M . The epidemiology of inflammatory bowel disease in Canada: a population-based study. Am J Gastroenterol. 2006; 101(7):1559-68. DOI: 10.1111/j.1572-0241.2006.00603.x. View

Bernstein C, Blanchard J, Rawsthorne P, Wajda A . Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. Am J Epidemiol. 1999; 149(10):916-24. DOI: 10.1093/oxfordjournals.aje.a009735. View

Baumgart D, Bernstein C, Abbas Z, Colombel J, Day A, DHaens G . IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting. Inflamm Bowel Dis. 2010; 17(2):639-44. DOI: 10.1002/ibd.21409. View

Garcia Rodriguez L, Gonzalez-Perez A, Johansson S, Wallander M . Risk factors for inflammatory bowel disease in the general population. Aliment Pharmacol Ther. 2005; 22(4):309-15. DOI: 10.1111/j.1365-2036.2005.02564.x. View

Chouraki V, Savoye G, Dauchet L, Vernier-Massouille G, Dupas J, Merle V . The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988-2007). Aliment Pharmacol Ther. 2011; 33(10):1133-42. DOI: 10.1111/j.1365-2036.2011.04628.x. View

10.

Ekbom A, HELMICK C, Zack M, Adami H . The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology. 1991; 100(2):350-8. DOI: 10.1016/0016-5085(91)90202-v. View

11.

Romberg-Camps M, de Kruijs M, Schouten L, Dagnelie P, Limonard C, Kester A . Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms. J Crohns Colitis. 2010; 3(2):115-24. DOI: 10.1016/j.crohns.2008.12.002. View

12.

Kappelman M, Moore K, Allen J, Cook S . Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population. Dig Dis Sci. 2012; 58(2):519-25. PMC: 3576554. DOI: 10.1007/s10620-012-2371-5. View

13.

Lowe A, Roy P, B-Poulin M, Michel P, Bitton A, St-Onge L . Epidemiology of Crohn's disease in Québec, Canada. Inflamm Bowel Dis. 2008; 15(3):429-35. DOI: 10.1002/ibd.20756. View

14.

Rezaie A, Quan H, Fedorak R, Panaccione R, Hilsden R . Development and validation of an administrative case definition for inflammatory bowel diseases. Can J Gastroenterol. 2012; 26(10):711-7. PMC: 3472911. DOI: 10.1155/2012/278495. View

15.

Loftus Jr E . The burden of inflammatory bowel disease in the United States: a moving target?. Clin Gastroenterol Hepatol. 2007; 5(12):1383-4. DOI: 10.1016/j.cgh.2007.10.016. View

16.

Green C, Elliott L, Beaudoin C, Bernstein C . A population-based ecologic study of inflammatory bowel disease: searching for etiologic clues. Am J Epidemiol. 2006; 164(7):615-23. DOI: 10.1093/aje/kwj260. View

17.

Hanauer S . Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2005; 12 Suppl 1:S3-9. DOI: 10.1097/01.mib.0000195385.19268.68. View

18.

Benchimol E, Fortinsky K, Gozdyra P, van den Heuvel M, Van Limbergen J, Griffiths A . Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis. 2010; 17(1):423-39. DOI: 10.1002/ibd.21349. View

19.

Molodecky N, Soon I, Rabi D, Ghali W, Ferris M, Chernoff G . Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology. 2011; 142(1):46-54.e42. DOI: 10.1053/j.gastro.2011.10.001. View

20.

Blanchard J, Bernstein C, Wajda A, Rawsthorne P . Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol. 2001; 154(4):328-35. DOI: 10.1093/aje/154.4.328. View